JOHNSON & JOHNSON Q1 2025 Filing
Filed May 7, 2025
Portfolio Value
$341.9B
Holdings
20
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (20 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PTGXProtagonist Therapeutics Inc. | 2,449,183 | $118.4B | 34.65% | |
| 2 | CVRXCVRx, Inc. | 4,103,430 | $50.2B | 14.68% | |
| 3 | MGTXMeiraGTx Holdings plc | 6,641,064 | $45.0B | 13.17% | |
| 4 | LEGNLegend Biotech Corporation | 814,586 | $27.6B | 8.08% | |
| 5 | RAPPRapport Therapeutics, Inc. | 2,498,051 | $25.1B | 7.33% | |
| 6 | PRCTProcept BioRobotics Corporation | 357,939 | $20.9B | 6.10% | |
| 7 | NBTXNanobiotix S.A. | 5,623,816 | $20.1B | 5.89% | |
| 8 | CTNMContineum Therapeutics Inc. | 1,979,173 | $13.8B | 4.04% | |
| 9 | XNCRXencor, Inc. | 748,062 | $8.0B | 2.33% | |
| 10 | ARWRArrowhead Pharmaceuticals, Inc. | 247,598 | $3.2B | 0.92% | |
| 11 | FATEFate Therapeutics, Inc. | 3,379,064 | $2.7B | 0.78% | |
| 12 | RLYBRallybio Corporation | 3,636,363 | $2.4B | 0.70% | |
| 13 | NMRANeumora Therapeutics, Inc. | 1,849,445 | $1.8B | 0.54% | |
| 14 | NNOXNano-X Imaging Ltd. | 158,852 | $793.5M | 0.23% | |
| 15 | VORVor Biopharma, Inc. | 1,074,658 | $771.1M | 0.23% | |
| 16 | LYELLyell Immunopharma Inc. | 823,317 | $442.9M | 0.13% | |
| 17 | FLBStandard BioTools Inc | 311,967 | $336.9M | 0.10% | |
| 18 | TORCEURAdicet Bio, Inc. | 364,472 | $275.2M | 0.08% | |
| 19 | PHGEBiomX Inc. | 96,866 | $53.8M | 0.02% | |
| 20 | SENS1GBPSenseonics Holdings, Inc. | 54,621 | $35.8M | 0.01% |